Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 4 of 4
-
ItemAn improved speech processor for a 22-electrode cochelar implant [Abstract]( 1992)A spectral maxima speech processing strategy ( SMSP) has been developed as a result of research to improve the speech perception performance of a multiple-channel cochlear implant. With this speech processing strategy. the six spectral maxima from the outputs of 16 band pass filters are used to stimulate the cochlea on a place basis at a constant rate. This SMSP strategy has been compared with the MSP-MULTIPEAK strategy, the present speech processor provided by Cochlear Pty. Limited, on four postlinguistically deaf adults. The study showed that the SMSP strategy was significantly better than the MSP-MULTJPEAK for the recognition of closed-set vowels and consonants, and open-set monosyllable words and sentences in background noise.
-
ItemMultichannel cochlear implants in children: an overview of experimental and clinical results at the University of Melbourne [Opening Lecture]( 1992)During the last decade there has been great progress in the clinical management of profound, postlinguistically deafened adults through the use of multichannel cochlear implants. The device developed by The University of Melbourne in association with Cochlear Pty Ltd, electrically stimulates selective regions of the auditory nerve using an array of 22 platinum (Pt) electrodes located in the scala tympani. Its development followed basic experimental studies and the development and evaluation of a prototype device in the 1970's. Following safety studies and a successful clinical trial, the Melbourne/Cochlear multichannel implant was approved for use in adults by the United States Food and Drug Administration (FDA) in 1985. More than 3000 patients throughout the world have since been implanted with this device, many being able to understand a significant amount of unfamiliar, connected speech without lipreading Following miniaturization of the implant, it became suitable for use with children. In 1990, after additional biological safety and clinical investigations, the FDA approved the use of the Melbourne/Cochlear multichannel implant for profoundly deaf children above the age of two years. And in 1991, the device received the medical device implantation approval certificate from the Japanese Government. The present paper presents an overview of our recent biological safety studies and clinical experience in children, and discusses the likely future development of these devices.
-
ItemFuture developments in speech processing for multichannel cochlear implants in children [Abstract]( 1992)The average speech perception score for adult implant patients is now about 60% on an open-set sentence test without lipreading. This is higher than the scores obtained by many profound and severe-to-profoundly impaired hearing aid users. This suggests that some hearing aid users, particularly those who use a hearing aid in one ear only, could benefit from a cochlear implant. As neither the implant nor the hearing aid will provide perfect speech recognition it is to be expected that this group should obtain maximum benefit by using the hearing aid in one ear together with the implant in the other ear. However, experience with this group of patients has shown that many people find the use of two independent devices unacceptable. Furthermore, perceptual interaction of the acoustic and electrical signals makes it desirable to be able to control the two outputs in a more co-ordinated way than is possible with two independent devices. Consequently, a "bimodal" speech processor has been developed with both acoustic and electrical outputs controlled from the same speech processing unit. Feature coding aspects of the implant processing have been applied to the acoustic signal in such a way as to enhance speech perception with the hearing aid and improve compatibility with the implant. Initial testing with the bimodal aid shows promise to help severely-to-profoundly impaired individuals. The device has also been useful as a research tool to investigate the complex interactions of simultaneous acoustic and electrical stimulation. The Spectral Maxima Sound Processor (SMSP) has also been developed at the University of Melbourne for use with the Nucleus cochlear implant. Studies with adult subjects have shown improved perception of vowels, consonants, words and sentences in quiet and sentences in background noise with the SMSP as compared with the MSP(MULTIPEAK) which is currently supplied for use with this implant. Results for four subjects showed mean scores for open set sentences at a 10 dB signal-to-noise ratio of 78.7% for the SMSP and 50.0% for the MSP. Mean scores for the same group on open set monosyllabic words in quiet were 57.4% for SMSP and 39.9% for MSP. These results suggest that future improvements in speech perception will be possible for children using the Nucleus cochlear implant.
-
ItemImprovements in speech processing for the nucleus cochlear implant [Abstract]( 1992)The Nucleus Cochlear implant allows ~ variety of multiple channel speech processing strategies to be developed and trialled. The initial strategy first developed by the University of Melbourne presented the second formant frequency as place and voicing as rate of stimulation. The strategy was subsequently improved by presenting the first format on a place basis as well. Since that time the addition of more spectral information coded as place of stimulation and temporal information presented as variations in amplitude have resulted in better open-set CNC word and sentence scores for electrical stimulation alone. One of the improved strategies selects four pairs of electrodes from the 22 electrode array each glottal pulse to present the first and second formants as well as the output from two high Frequency band pass filters. The other strategy stimulates six of the 22 electrodes representing the six maximal outputs from 16 bandpass filters. The clinical results have shown that both the above strategies results in better open-set speech perception for electrical stimulation in quiet and in noise. 80 % scores have been obtained for open-sets of CNC words and 90 % for open-sets of words in sentences for some of the patients using the latter strategy.